# Harvard Business School: Cannabis Economics & Clinical Reality > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/videos/harvard-business-school-lectures/ > **Published:** 2026-10-08T21:26:35-04:00 | **Last Modified / Clinically Audited:** 2026-10-31T14:39:19-04:00 > **Clinical Summary:** Watch Dr. Benjamin Caplan's invited keynote lectures at Harvard Business School analyzing healthcare economics, clinical realities, and the cannabis industry. --- [Home](https://cedclinic.com/) / [Video Archive & Media Hub](https://cedclinic.com/videos/) / Harvard Business School Lectures ๐Ÿ›๏ธ Academic Keynote & Healthcare Economics Table of Contents - [Harvard Business School: Cannabis Economics & Clinical Reality](#Harvard_Business_School_Cannabis_Economics_038_Clinical_Reality)[Executive Summary: The Friction Between Profit Margins and Patient Care](#Executive_Summary_The_Friction_Between_Profit_Margins_and_Patient_Care) - [The 4 Structural Dilemmas in Cannabis Economics](#The_4_Structural_Dilemmas_in_Cannabis_Economics)[๐Ÿ“‰ The Fallacy of โ€˜High THCโ€™ As Quality](#_The_Fallacy_of_8216High_THC8217_As_Quality) - [๐Ÿ›ก๏ธ Physician Oversight as Market De-Risking](#_Physician_Oversight_as_Market_De-Risking) - [๐Ÿ’ฐ Health Insurance & Payer Economics](#_Health_Insurance_038_Payer_Economics) - [โš–๏ธ Regulatory Arbitrage & Schedule III](#_Regulatory_Arbitrage_038_Schedule_III) - [Massachusetts 60-Day Rolling Supply Limit: Patient Protections](#Massachusetts_60-Day_Rolling_Supply_Limit_Patient_Protections) - [Explore Academic & Media Archives](#Explore_Academic_038_Media_Archives)[๐ŸŽ“ Doctor-to-Doctor Grand Rounds](#_Doctor-to-Doctor_Grand_Rounds) - [๐Ÿ›๏ธ Federal Policy & DEA Rescheduling](#_Federal_Policy_038_DEA_Rescheduling) - [๐ŸŽ™๏ธ Video Podcast Masterclass](#_Video_Podcast_Masterclass) - [๐ŸŒ Voice of America Documentary](#_Voice_of_America_Documentary) - [Seek Guidance from a Nationally Recognized Leader](#Seek_Guidance_from_a_Nationally_Recognized_Leader) # Harvard Business School: Cannabis Economics & Clinical Reality Dr. Benjamin Caplan delivers an invited lecture series at Harvard Business School addressing MBA candidates, researchers, and venture faculty on the collision between commercial cannabis venture capital and frontline patient health. ๐ŸŽ“ Harvard Business School Invited Series ๐Ÿ’ผ Venture Capital vs. Medical Truth โš–๏ธ Ethics in Regulated Markets โ— Featured Harvard Academic Series Harvard Business School Archive [โ–ถ Watch Full HBS Lecture Series Playlist on YouTube โ†—](https://www.youtube.com/playlist?list=PLkWZIqAyGpbXxdUKbHiHuuN3c-zqJ0SlL) ### Executive Summary: The Friction Between Profit Margins and Patient Care Speaking to future global healthcare executives and investors at Harvard Business School, Dr. Benjamin Caplan exposes the structural misalignments of the commercial cannabis sector. When corporate dispensaries compete purely on THC potency and sugary branding, medical patients suffering from severe [chronic pain](https://cedclinic.com/cbd-gummies-chronic-pain/), autoimmune diseases, and oncology trauma are abandoned. Dr. Caplan lays out the clinical blueprint for sustainable healthcare ventures: integrating physician-guided titration, verifiable third-party testing, and health-insurer reimbursement frameworks. [Launch YouTube HBS Playlist โ†—](https://www.youtube.com/playlist?list=PLkWZIqAyGpbXxdUKbHiHuuN3c-zqJ0SlL) [Schedule Clinical Consultation โ†—](https://cedclinic.com/contact-ced-staff/) Business School Keynotes ## The 4 Structural Dilemmas in Cannabis Economics Key frameworks presented in Dr. Caplanโ€™s Harvard lecture series. Market Misconception #### ๐Ÿ“‰ The Fallacy of โ€˜High THCโ€™ As Quality Commercial markets incentivize cultivators to breed for sky-high THC percentages, destroying fragile terpene profiles and minor cannabinoid ratios that provide therapeutic stability. Clinical Governance #### ๐Ÿ›ก๏ธ Physician Oversight as Market De-Risking Without trained clinician oversight, patients experience adverse dosing events, panic, and product abandonment. Clinical guidance transforms frustrated consumers into adherent, thriving patients. Cost Containment #### ๐Ÿ’ฐ Health Insurance & Payer Economics Commercial insurers currently spend hundreds of billions managing opioid overdoses, polypharmacy interactions, and surgical complications. Reimbursing clinician-guided cannabis regimens yields major net savings. Federal Policy #### โš–๏ธ Regulatory Arbitrage & Schedule III How federal reclassification to Schedule III disrupts Section 280E taxation while introducing complex FDA prescription and investigational new drug (IND) hurdles for operators. ๐Ÿ“œ State Law Patient Legal Rights & State Supply Limits ### Massachusetts 60-Day Rolling Supply Limit: Patient Protections Under Massachusetts Cannabis Control Commission (CCC) regulations, certified medical patients have legal authorization to purchase and possess up to a 60-day rolling supply (up to 10 ounces). Read Dr. Caplanโ€™s clinical breakdown of certified patient rights, sales-tax exemptions, and regulatory protections. [Read Massachusetts 60-Day Supply Guide โ†—](https://cedclinic.com/massachusetts-60-day-rolling-supply-limit-medical-cannabis-2026/) Related Video Hubs & Clinical Archives ### Explore Academic & Media Archives #### ๐ŸŽ“ Doctor-to-Doctor Grand Rounds Pharmacology keynotes, hospital physician ethics, and CYP450 drug interaction lectures. [Watch Grand Rounds โ†—](https://cedclinic.com/videos/doctor-grand-rounds-clinical-pharmacology/) #### ๐Ÿ›๏ธ Federal Policy & DEA Rescheduling FOX 5 DC live coverage and congressional testimony on Schedule III classification and insurance parity. [Watch Policy Hub โ†—](https://cedclinic.com/videos/federal-policy-dea-rescheduling/) #### ๐ŸŽ™๏ธ Video Podcast Masterclass Five long-form clinical video podcasts exploring titration, terpenes, and healthcare economics. [Watch Video Podcasts โ†—](https://cedclinic.com/videos/video-podcast-masterclass-series/) #### ๐ŸŒ Voice of America Documentary International documentary profiling Cฤ’D Clinicโ€™s clinical care blueprint broadcast to 300M+ viewers. [Watch VOA Feature โ†—](https://cedclinic.com/videos/voice-of-america-cannabis-documentary/) Expert Clinical Consultation ### Seek Guidance from a Nationally Recognized Leader Whether you are an individual patient navigating severe health hurdles or an institutional team seeking medical advisory expertise, Dr. Benjamin Caplan provides world-class clinical guidance. [Book Clinical Consultation โ†—](https://cedclinic.com/contact-ced-staff/) [Explore Dr. Caplanโ€™s Handbook โ†—](https://www.DoctorApprovedCannabisHandbook.com) --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR ยง 164.514(b)) and criteria for secondary research exemption under 45 CFR ยง 46.104(d)(4).